Erratum to: Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine reduces of 1.5 log copies/mL the HIV RNA rebound median and no HIV DNA rebound following cART interruption in a phase I/II randomized controlled clinical trial [Retrovirology. 2016; 13, 21], doi: 10.1186/s12977-016-0251-3.]

Loret, E. P., Darque, A., Jouve, E., Loret, E. A., Nicolino-Brunet, C., Morange, S., … Ravaux, I. (2016, May 9). Erratum to: Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine reduces of 1.5 log copies/mL the HIV RNA rebound median and no HIV DNA rebound following cART interruption in a phase I/II randomized controlled clinical trial [Retrovirology. 2016; 13, 21], doi: 10.1186/s12977-016-0251-3.]. Retrovirology. BioMed Central Ltd. https://doi.org/10.1186/s12977-016-0264-y